Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
3
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Regeneron Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 23 Analysts
Dupixent And EYLEA Will Seize Expanding Global Markets
Key Takeaways Regeneron's best-in-class therapies, strong product adoption, and innovative pipeline position it for rapid market share gains and expanded, diversified long-term growth. Strategic investments in manufacturing and advanced biologics platforms enable operational efficiency, robust supply, and capitalize on rising global demand for precision medicines.
View narrative
US$815.00
FV
28.8% undervalued
intrinsic discount
7.63%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Analog Devices
AN
AnalystHighTarget
Consensus Narrative from 32 Analysts
IoT, Electric Vehicles And Digital Health Will Expand Markets
Key Takeaways Growth in industrial automation, automotive sensing, and edge intelligence is driving long-term revenue streams and higher margins through innovative, high-density, low-power solutions. Strategic expansion into digital healthcare, AI infrastructure, and advanced manufacturing enhances market share, operational resilience, and profitability across multiple high-growth sectors.
View narrative
US$300.00
FV
22.8% undervalued
intrinsic discount
16.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Bristol-Myers Squibb
AN
AnalystHighTarget
Consensus Narrative from 21 Analysts
Pipeline Launches And Global Healthcare Trends Will Unlock Growth
Key Takeaways Robust portfolio performance and pipeline innovation, especially in immuno-oncology, are fueling faster-than-expected revenue growth and international market expansion. Strong cost discipline, operational efficiencies, and AI-driven R&D enhancements are creating substantial upside for margins and long-term earnings growth.
View narrative
US$68.00
FV
28.8% undervalued
intrinsic discount
-3.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
TJX Companies
AN
AnalystHighTarget
Consensus Narrative from 18 Analysts
Global Store Openings And E-Commerce Investment Will Unlock Opportunities
Key Takeaways Strategic global expansion and e-commerce enhancement are poised to drive sales growth and improve online presence. Smart buying strategies and operational investments are set to positively impact profitability and foster earnings growth.
View narrative
US$164.00
FV
19.1% undervalued
intrinsic discount
7.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Vertex Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 25 Analysts
Gene Editing And Precision Medicines Will Serve Aging Populations
Key Takeaways Superior new treatments and breakthrough therapies are set to accelerate growth, replace older products, and drive market leadership in chronic and genetic diseases. Strong financials enable aggressive R&D, pipeline expansion, and strategic deals, supporting sustained margin growth and earnings outperformance.
View narrative
US$623.72
FV
37.0% undervalued
intrinsic discount
13.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
NextEra Energy
AN
AnalystHighTarget
Consensus Narrative from 18 Analysts
Accelerated Decarbonization And Electrification Will Reshape Energy Markets
Key Takeaways NextEra's scale, advanced storage, and unique asset repositioning could lead to outperformance in revenue, margins, and market share as energy demand accelerates. Aggressive investments in nuclear, grid digitalization, and all-source solutions position NextEra for sustained growth and premium pricing in a rapidly electrifying economy.
View narrative
US$103.00
FV
26.8% undervalued
intrinsic discount
15.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
United Parcel Service
AN
AnalystHighTarget
Consensus Narrative from 30 Analysts
Omni-channel Retail And Automation Will Unlock Global Efficiency
Key Takeaways Rapid automation and cost-cutting efforts are improving margins, product mix, and cash flow, with potential to exceed market expectations for sustainable profitability. Strategic expansion in healthcare logistics and global trade routes, combined with digital investments, is positioning the company for robust, diversified long-term growth.
View narrative
US$133.00
FV
33.5% undervalued
intrinsic discount
2.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
International Business Machines
AN
AnalystHighTarget
Consensus Narrative from 19 Analysts
Hybrid Cloud And GenAI Will Unlock Enduring Digital Opportunities
Key Takeaways Accelerated adoption of AI, hybrid cloud, and modernization in regulated sectors positions IBM for outsized share of expanding digital transformation budgets and long-term profitability. Integration of acquired platforms and innovation in quantum computing and automation enhance high-margin software growth, driving sustained revenue outperformance and premium valuation.
View narrative
US$350.00
FV
31.5% undervalued
intrinsic discount
6.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
3 days ago
author updated this narrative
Amgen
AN
AnalystHighTarget
Consensus Narrative from 26 Analysts
Biosimilars And Targeted Therapies Will Expand Global Chronic Care Markets
Key Takeaways Expanding product volumes and AI-driven R&D advancements position Amgen to exceed revenue and margin expectations through frequent, high-impact new launches across key therapeutic areas. Strong resilience to industry pricing pressures, global expansion, and ample M&A capacity enable Amgen to unlock long-term earnings growth and broaden its market reach.
View narrative
US$405.00
FV
26.8% undervalued
intrinsic discount
7.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies